These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 27801706)

  • 1. Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials.
    Sullivan SD; Lehman A; Nathan NK; Thomson CA; Howard BV
    Menopause; 2017 Apr; 24(4):371-378. PubMed ID: 27801706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study.
    Sullivan SD; Lehman A; Thomas F; Johnson KC; Jackson R; Wactawski-Wende J; Ko M; Chen Z; Curb JD; Howard BV
    Menopause; 2015 Oct; 22(10):1035-44. PubMed ID: 25803670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
    Manson JE; Crandall CJ; Rossouw JE; Chlebowski RT; Anderson GL; Stefanick ML; Aragaki AK; Cauley JA; Wells GL; LaCroix AZ; Thomson CA; Neuhouser ML; Van Horn L; Kooperberg C; Howard BV; Tinker LF; Wactawski-Wende J; Shumaker SA; Prentice RL
    JAMA; 2024 May; 331(20):1748-1760. PubMed ID: 38691368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium plus vitamin D supplementation and the risk of fractures.
    Jackson RD; LaCroix AZ; Gass M; Wallace RB; Robbins J; Lewis CE; Bassford T; Beresford SA; Black HR; Blanchette P; Bonds DE; Brunner RL; Brzyski RG; Caan B; Cauley JA; Chlebowski RT; Cummings SR; Granek I; Hays J; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Johnson KC; Judd H; Kotchen JM; Kuller LH; Langer RD; Lasser NL; Limacher MC; Ludlam S; Manson JE; Margolis KL; McGowan J; Ockene JK; O'Sullivan MJ; Phillips L; Prentice RL; Sarto GE; Stefanick ML; Van Horn L; Wactawski-Wende J; Whitlock E; Anderson GL; Assaf AR; Barad D;
    N Engl J Med; 2006 Feb; 354(7):669-83. PubMed ID: 16481635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.
    Bolland MJ; Grey A; Gamble GD; Reid IR
    Am J Clin Nutr; 2011 Oct; 94(4):1144-9. PubMed ID: 21880848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy.
    Robbins JA; Aragaki A; Crandall CJ; Manson JE; Carbone L; Jackson R; Lewis CE; Johnson KC; Sarto G; Stefanick ML; Wactawski-Wende J
    Menopause; 2014 Feb; 21(2):116-23. PubMed ID: 23799356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.
    Control Clin Trials; 1998 Feb; 19(1):61-109. PubMed ID: 9492970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials.
    Canonico M; Plu-Bureau G; O'Sullivan MJ; Stefanick ML; Cochrane B; Scarabin PY; Manson JE
    Menopause; 2014 Mar; 21(3):214-20. PubMed ID: 23760439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
    Jackson RD; Wactawski-Wende J; LaCroix AZ; Pettinger M; Yood RA; Watts NB; Robbins JA; Lewis CE; Beresford SA; Ko MG; Naughton MJ; Satterfield S; Bassford T;
    J Bone Miner Res; 2006 Jun; 21(6):817-28. PubMed ID: 16753012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial.
    LaCroix AZ; Kotchen J; Anderson G; Brzyski R; Cauley JA; Cummings SR; Gass M; Johnson KC; Ko M; Larson J; Manson JE; Stefanick ML; Wactawski-Wende J
    J Gerontol A Biol Sci Med Sci; 2009 May; 64(5):559-67. PubMed ID: 19221190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Women's Health Initiative: Hormone Therapy and Calcium/Vitamin D supplementation trials.
    Cauley JA
    Curr Osteoporos Rep; 2013 Sep; 11(3):171-8. PubMed ID: 23842639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study.
    Barad D; Kooperberg C; Wactawski-Wende J; Liu J; Hendrix SL; Watts NB
    Fertil Steril; 2005 Aug; 84(2):374-83. PubMed ID: 16084878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What to do about postmenopausal fracture risk. Diet, exercise, calcium, and vitamin D are always important, but women at high risk for fractures may need drug therapy, too.
    Harv Womens Health Watch; 2009 Dec; 17(4):1-3. PubMed ID: 20088086
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopause and postmenopausal hormone therapy and risk of hearing loss.
    Curhan SG; Eliassen AH; Eavey RD; Wang M; Lin BM; Curhan GC
    Menopause; 2017 Sep; 24(9):1049-1056. PubMed ID: 28486246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.
    Cauley JA; Chlebowski RT; Wactawski-Wende J; Robbins JA; Rodabough RJ; Chen Z; Johnson KC; O'Sullivan MJ; Jackson RD; Manson JE
    J Womens Health (Larchmt); 2013 Nov; 22(11):915-29. PubMed ID: 24131320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization.
    Karim R; Dell RM; Greene DF; Mack WJ; Gallagher JC; Hodis HN
    Menopause; 2011 Nov; 18(11):1172-7. PubMed ID: 21775911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Weaver CM; Alexander DD; Boushey CJ; Dawson-Hughes B; Lappe JM; LeBoff MS; Liu S; Looker AC; Wallace TC; Wang DD
    Osteoporos Int; 2016 Jan; 27(1):367-76. PubMed ID: 26510847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.